Evidence map›Paper›PMID 38474769›Full record

ReviewNutrients2024

Beneficial Effects of

Valeria Prete, Angela Carmelita Abate, Paola Di Pietro, Massimiliano De Lucia, Carmine Vecchione, Albino Carrizzo

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pharmacological insights intoFrontiers in pharmacology · 2025
    Pooled it
  2. Review
  3. Article
  4. Molecules (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Neuroprotective and Antioxidant Study ofCurrent aging science · 2026
    Article
  8. Review
  9. A novelFrontiers in immunology · 2026
    Article
  10. Review
  11. Article
  12. International journal of molecular sciences · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Unveiling the Potential of Silymarin,Life (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Valeria PreteDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0009-0006-2380-1611
Angela Carmelita AbateDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0009-0007-2811-8018
Paola Di PietroDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0000-0003-1327-1961
Massimiliano De LuciaVascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy.
Carmine VecchioneDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
Albino CarrizzoDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0000-0003-2689-0008
University of Salerno · ITIstituto Neurologico Mediterraneo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent decades, as a result of rising mortality rates due to cardiovascular diseases (CVDs), there has been a growing urgency to find alternative approaches to conventional pharmaceutical treatment to prevent the onset of chronic diseases.

Indexed as

Cardiovascular DiseasesSpirulinaDietary SupplementsHumansHypoglycemic AgentsHypolipidemic AgentsHypoglycemic AgentsHypolipidemic Agentscardiovascular and cerebrovascular diseaseshyperlipidemiahypertensionSpirulinatype 2 diabetes

Identifiers

PMID38474769
PMCPMC10935118
OpenAlexW4392166637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.